CN100368002C - 一种外用止痛药物及其制备方法 - Google Patents
一种外用止痛药物及其制备方法 Download PDFInfo
- Publication number
- CN100368002C CN100368002C CNB2006100108327A CN200610010832A CN100368002C CN 100368002 C CN100368002 C CN 100368002C CN B2006100108327 A CNB2006100108327 A CN B2006100108327A CN 200610010832 A CN200610010832 A CN 200610010832A CN 100368002 C CN100368002 C CN 100368002C
- Authority
- CN
- China
- Prior art keywords
- radix
- parts
- caulis
- herba
- radix aconiti
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 230000000202 analgesic effect Effects 0.000 title claims abstract description 14
- 238000002360 preparation method Methods 0.000 title claims description 16
- 239000003814 drug Substances 0.000 claims abstract description 52
- 229940079593 drug Drugs 0.000 claims abstract description 22
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 53
- 235000003143 Panax notoginseng Nutrition 0.000 claims description 30
- 241000180649 Panax notoginseng Species 0.000 claims description 30
- 238000002156 mixing Methods 0.000 claims description 24
- 241000628997 Flos Species 0.000 claims description 19
- 239000004615 ingredient Substances 0.000 claims description 19
- 238000005325 percolation Methods 0.000 claims description 18
- 239000000843 powder Substances 0.000 claims description 17
- DTGKSKDOIYIVQL-WEDXCCLWSA-N (+)-borneol Chemical compound C1C[C@@]2(C)[C@@H](O)C[C@@H]1C2(C)C DTGKSKDOIYIVQL-WEDXCCLWSA-N 0.000 claims description 11
- 239000012567 medical material Substances 0.000 claims description 11
- 241001263603 Stellera Species 0.000 claims description 10
- 239000007788 liquid Substances 0.000 claims description 9
- 238000010992 reflux Methods 0.000 claims description 9
- 238000001914 filtration Methods 0.000 claims description 8
- 239000000203 mixture Substances 0.000 claims description 8
- 241001111214 Fibraurea Species 0.000 claims description 7
- 239000000463 material Substances 0.000 claims description 6
- 239000000443 aerosol Substances 0.000 claims description 4
- 239000007921 spray Substances 0.000 claims description 4
- 238000005538 encapsulation Methods 0.000 claims description 3
- 239000003380 propellant Substances 0.000 claims description 3
- 239000000758 substrate Substances 0.000 claims description 3
- 239000002994 raw material Substances 0.000 claims description 2
- 239000004480 active ingredient Substances 0.000 claims 1
- 208000002193 Pain Diseases 0.000 abstract description 35
- 230000036407 pain Effects 0.000 abstract description 32
- 230000000694 effects Effects 0.000 abstract description 15
- 229940035676 analgesics Drugs 0.000 abstract description 6
- 239000000730 antalgic agent Substances 0.000 abstract description 6
- 241000227129 Aconitum Species 0.000 abstract description 3
- 230000036592 analgesia Effects 0.000 abstract description 3
- 230000008901 benefit Effects 0.000 abstract description 3
- 210000003205 muscle Anatomy 0.000 abstract description 3
- 206010012335 Dependence Diseases 0.000 abstract description 2
- 241000759271 Alangium Species 0.000 abstract 1
- 235000002470 Asclepias syriaca Nutrition 0.000 abstract 1
- 206010058019 Cancer Pain Diseases 0.000 abstract 1
- 208000003044 Closed Fractures Diseases 0.000 abstract 1
- 244000166124 Eucalyptus globulus Species 0.000 abstract 1
- 206010024453 Ligament sprain Diseases 0.000 abstract 1
- 206010050031 Muscle strain Diseases 0.000 abstract 1
- 208000001294 Nociceptive Pain Diseases 0.000 abstract 1
- 241000893851 Periploca graeca Species 0.000 abstract 1
- 239000009759 San-Chi Substances 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 239000002552 dosage form Substances 0.000 abstract 1
- 210000004872 soft tissue Anatomy 0.000 abstract 1
- 238000012360 testing method Methods 0.000 description 14
- 230000008034 disappearance Effects 0.000 description 11
- 239000008280 blood Substances 0.000 description 9
- 210000004369 blood Anatomy 0.000 description 9
- 208000024891 symptom Diseases 0.000 description 8
- 230000017531 blood circulation Effects 0.000 description 6
- 238000005303 weighing Methods 0.000 description 6
- 238000006243 chemical reaction Methods 0.000 description 5
- 230000003203 everyday effect Effects 0.000 description 5
- 238000007689 inspection Methods 0.000 description 4
- 238000000034 method Methods 0.000 description 4
- 241000196324 Embryophyta Species 0.000 description 3
- 208000026137 Soft tissue injury Diseases 0.000 description 3
- 208000027418 Wounds and injury Diseases 0.000 description 3
- 230000001154 acute effect Effects 0.000 description 3
- 230000003110 anti-inflammatory effect Effects 0.000 description 3
- 238000005516 engineering process Methods 0.000 description 3
- 230000023597 hemostasis Effects 0.000 description 3
- 239000000865 liniment Substances 0.000 description 3
- 229940040145 liniment Drugs 0.000 description 3
- 230000001737 promoting effect Effects 0.000 description 3
- 206010039073 rheumatoid arthritis Diseases 0.000 description 3
- 208000032912 Local swelling Diseases 0.000 description 2
- 241000283973 Oryctolagus cuniculus Species 0.000 description 2
- 241000218201 Ranunculaceae Species 0.000 description 2
- 206010070834 Sensitisation Diseases 0.000 description 2
- 230000003213 activating effect Effects 0.000 description 2
- 238000013459 approach Methods 0.000 description 2
- OROGSEYTTFOCAN-DNJOTXNNSA-N codeine Chemical compound C([C@H]1[C@H](N(CC[C@@]112)C)C3)=C[C@H](O)[C@@H]1OC1=C2C3=CC=C1OC OROGSEYTTFOCAN-DNJOTXNNSA-N 0.000 description 2
- 239000000470 constituent Substances 0.000 description 2
- 230000007812 deficiency Effects 0.000 description 2
- 230000008451 emotion Effects 0.000 description 2
- 238000000605 extraction Methods 0.000 description 2
- 210000003414 extremity Anatomy 0.000 description 2
- 239000000796 flavoring agent Substances 0.000 description 2
- 235000019634 flavors Nutrition 0.000 description 2
- 229930182470 glycoside Natural products 0.000 description 2
- 150000002338 glycosides Chemical class 0.000 description 2
- 210000002216 heart Anatomy 0.000 description 2
- 208000014674 injury Diseases 0.000 description 2
- 210000004185 liver Anatomy 0.000 description 2
- 210000004072 lung Anatomy 0.000 description 2
- 230000007246 mechanism Effects 0.000 description 2
- BQJCRHHNABKAKU-KBQPJGBKSA-N morphine Chemical compound O([C@H]1[C@H](C=C[C@H]23)O)C4=C5[C@@]12CCN(C)[C@@H]3CC5=CC=C4O BQJCRHHNABKAKU-KBQPJGBKSA-N 0.000 description 2
- 239000002674 ointment Substances 0.000 description 2
- BASFCYQUMIYNBI-UHFFFAOYSA-N platinum Chemical compound [Pt] BASFCYQUMIYNBI-UHFFFAOYSA-N 0.000 description 2
- 231100000614 poison Toxicity 0.000 description 2
- 230000002040 relaxant effect Effects 0.000 description 2
- 230000008313 sensitization Effects 0.000 description 2
- 210000000952 spleen Anatomy 0.000 description 2
- 230000008961 swelling Effects 0.000 description 2
- 230000001225 therapeutic effect Effects 0.000 description 2
- 239000003440 toxic substance Substances 0.000 description 2
- XFSBVAOIAHNAPC-XTHSEXKGSA-N 16-Ethyl-1alpha,6alpha,19beta-trimethoxy-4-(methoxymethyl)-aconitane-3alpha,8,10alpha,11,18alpha-pentol, 8-acetate 10-benzoate Chemical compound O([C@H]1[C@]2(O)C[C@H]3[C@@]45C6[C@@H]([C@@]([C@H]31)(OC(C)=O)[C@@H](O)[C@@H]2OC)[C@H](OC)[C@@H]4[C@]([C@@H](C[C@@H]5OC)O)(COC)CN6CC)C(=O)C1=CC=CC=C1 XFSBVAOIAHNAPC-XTHSEXKGSA-N 0.000 description 1
- USSIQXCVUWKGNF-UHFFFAOYSA-N 6-(dimethylamino)-4,4-diphenylheptan-3-one Chemical compound C=1C=CC=CC=1C(CC(C)N(C)C)(C(=O)CC)C1=CC=CC=C1 USSIQXCVUWKGNF-UHFFFAOYSA-N 0.000 description 1
- XFSBVAOIAHNAPC-UHFFFAOYSA-N Aconitin Natural products CCN1CC(C(CC2OC)O)(COC)C3C(OC)C(C(C45)(OC(C)=O)C(O)C6OC)C1C32C4CC6(O)C5OC(=O)C1=CC=CC=C1 XFSBVAOIAHNAPC-UHFFFAOYSA-N 0.000 description 1
- 241001104932 Aconitum austroyunnanense Species 0.000 description 1
- 241000303966 Aconitum brachypodum Species 0.000 description 1
- 244000130463 Alangium chinense Species 0.000 description 1
- 208000019901 Anxiety disease Diseases 0.000 description 1
- 208000031636 Body Temperature Changes Diseases 0.000 description 1
- 241000700199 Cavia porcellus Species 0.000 description 1
- 241000758719 Chloranthaceae Species 0.000 description 1
- 241000721156 Chloranthus spicatus Species 0.000 description 1
- 244000117499 Colubrina elliptica Species 0.000 description 1
- 241000142975 Cornaceae Species 0.000 description 1
- 241001048935 Dendrobium chryseum Species 0.000 description 1
- 101100075837 Drosophila melanogaster Mabi gene Proteins 0.000 description 1
- 206010014080 Ecchymosis Diseases 0.000 description 1
- HEFNNWSXXWATRW-UHFFFAOYSA-N Ibuprofen Chemical compound CC(C)CC1=CC=C(C(C)C(O)=O)C=C1 HEFNNWSXXWATRW-UHFFFAOYSA-N 0.000 description 1
- 206010062717 Increased upper airway secretion Diseases 0.000 description 1
- XADCESSVHJOZHK-UHFFFAOYSA-N Meperidine Chemical compound C=1C=CC=CC=1C1(C(=O)OCC)CCN(C)CC1 XADCESSVHJOZHK-UHFFFAOYSA-N 0.000 description 1
- 241000699666 Mus <mouse, genus> Species 0.000 description 1
- 241000699670 Mus sp. Species 0.000 description 1
- 241000753128 Periploca <moth> Species 0.000 description 1
- 241000991518 Periploca calophylla Species 0.000 description 1
- 241000722363 Piper Species 0.000 description 1
- 241000758706 Piperaceae Species 0.000 description 1
- 208000005374 Poisoning Diseases 0.000 description 1
- 206010040880 Skin irritation Diseases 0.000 description 1
- 241001263604 Stellera chamaejasme Species 0.000 description 1
- 206010045171 Tumour pain Diseases 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 230000005856 abnormality Effects 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 229940039750 aconitine Drugs 0.000 description 1
- STDXGNLCJACLFY-UHFFFAOYSA-N aconitine Natural products CCN1CC2(COC)C(O)CC(O)C34C5CC6(O)C(OC)C(O)C(OC(=O)C)(C5C6OC(=O)c7ccccc7)C(C(OC)C23)C14 STDXGNLCJACLFY-UHFFFAOYSA-N 0.000 description 1
- 231100000215 acute (single dose) toxicity testing Toxicity 0.000 description 1
- 231100000403 acute toxicity Toxicity 0.000 description 1
- 230000007059 acute toxicity Effects 0.000 description 1
- 238000011047 acute toxicity test Methods 0.000 description 1
- 210000004100 adrenal gland Anatomy 0.000 description 1
- 229930013930 alkaloid Natural products 0.000 description 1
- 150000003797 alkaloid derivatives Chemical class 0.000 description 1
- 230000002052 anaphylactic effect Effects 0.000 description 1
- 230000036506 anxiety Effects 0.000 description 1
- 229940049706 benzodiazepine Drugs 0.000 description 1
- 150000001557 benzodiazepines Chemical class 0.000 description 1
- 238000009534 blood test Methods 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 230000003177 cardiotonic effect Effects 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 229940126678 chinese medicines Drugs 0.000 description 1
- 230000004087 circulation Effects 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 229960004126 codeine Drugs 0.000 description 1
- 238000011109 contamination Methods 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 230000002354 daily effect Effects 0.000 description 1
- 230000035487 diastolic blood pressure Effects 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 210000000245 forearm Anatomy 0.000 description 1
- 230000006870 function Effects 0.000 description 1
- 230000035876 healing Effects 0.000 description 1
- OROGSEYTTFOCAN-UHFFFAOYSA-N hydrocodone Natural products C1C(N(CCC234)C)C2C=CC(O)C3OC2=C4C1=CC=C2OC OROGSEYTTFOCAN-UHFFFAOYSA-N 0.000 description 1
- 229960001680 ibuprofen Drugs 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 230000000968 intestinal effect Effects 0.000 description 1
- 210000003734 kidney Anatomy 0.000 description 1
- 230000003907 kidney function Effects 0.000 description 1
- 210000002429 large intestine Anatomy 0.000 description 1
- 231100001252 long-term toxicity Toxicity 0.000 description 1
- 239000006210 lotion Substances 0.000 description 1
- 239000002932 luster Substances 0.000 description 1
- 231100000682 maximum tolerated dose Toxicity 0.000 description 1
- 229960001797 methadone Drugs 0.000 description 1
- 230000004089 microcirculation Effects 0.000 description 1
- 229960005181 morphine Drugs 0.000 description 1
- 239000003158 myorelaxant agent Substances 0.000 description 1
- 239000004084 narcotic analgesic agent Substances 0.000 description 1
- 231100000957 no side effect Toxicity 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 210000001672 ovary Anatomy 0.000 description 1
- 210000000496 pancreas Anatomy 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- 230000000149 penetrating effect Effects 0.000 description 1
- 229960000482 pethidine Drugs 0.000 description 1
- 230000000144 pharmacologic effect Effects 0.000 description 1
- 208000026435 phlegm Diseases 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 229910052697 platinum Inorganic materials 0.000 description 1
- 231100000572 poisoning Toxicity 0.000 description 1
- 230000000607 poisoning effect Effects 0.000 description 1
- 230000037452 priming Effects 0.000 description 1
- 239000001397 quillaja saponaria molina bark Substances 0.000 description 1
- 230000029058 respiratory gaseous exchange Effects 0.000 description 1
- 201000003068 rheumatic fever Diseases 0.000 description 1
- 229930182490 saponin Natural products 0.000 description 1
- 150000007949 saponins Chemical class 0.000 description 1
- 230000036556 skin irritation Effects 0.000 description 1
- 231100000475 skin irritation Toxicity 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 230000000638 stimulation Effects 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 230000009897 systematic effect Effects 0.000 description 1
- 230000035488 systolic blood pressure Effects 0.000 description 1
- 210000002435 tendon Anatomy 0.000 description 1
- 210000001550 testis Anatomy 0.000 description 1
- 210000001541 thymus gland Anatomy 0.000 description 1
- 210000001685 thyroid gland Anatomy 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 238000011200 topical administration Methods 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 230000008736 traumatic injury Effects 0.000 description 1
- 210000004291 uterus Anatomy 0.000 description 1
- 239000000341 volatile oil Substances 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
Description
试验组 | 1次用量 | 日用次数 | 日用量 | 用药天数 | 受试人数 |
第1组 | 1.25ml | 4次 | 5ml | 1天 | 4人 |
第2组 | 2.50ml | 4次 | 10ml | 1天 | 4人 |
第3组 | 5.0ml | 4次 | 20ml | 1天 | 4人 |
第4组 | 5.0ml | 6次 | 30ml | 2天 | 6人 |
第5组 | 5.0ml | 8次 | 40ml | 4天 | 6人 |
第6组 | 5.0ml | 8次 | 40ml | 7天 | 6人 |
Claims (10)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNB2006100108327A CN100368002C (zh) | 2006-04-19 | 2006-04-19 | 一种外用止痛药物及其制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CNB2006100108327A CN100368002C (zh) | 2006-04-19 | 2006-04-19 | 一种外用止痛药物及其制备方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN1876034A CN1876034A (zh) | 2006-12-13 |
CN100368002C true CN100368002C (zh) | 2008-02-13 |
Family
ID=37508703
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CNB2006100108327A Expired - Fee Related CN100368002C (zh) | 2006-04-19 | 2006-04-19 | 一种外用止痛药物及其制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN100368002C (zh) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102008576B (zh) * | 2010-11-29 | 2012-05-30 | 昆明理工大学 | 一种治疗扭伤的外用中药及其制备方法 |
CN103083489B (zh) * | 2013-01-24 | 2014-09-17 | 王林祥 | 治腰椎病、颈椎病、骨质增生早期、陈年旧伤的中药酒剂 |
CN104042815A (zh) * | 2014-06-28 | 2014-09-17 | 张志全 | 一种治疗癌症疼痛的中药膏药 |
CN104353023A (zh) * | 2014-10-21 | 2015-02-18 | 苏州仁捷瑞自动化科技有限公司 | 一种活血接骨药膏贴及其制备方法 |
CN106389742A (zh) * | 2016-10-09 | 2017-02-15 | 上海民生志远健康管理科技发展有限公司 | 一种治疗癌性疼痛的中药组合物 |
CN114832055A (zh) * | 2022-01-12 | 2022-08-02 | 贵州中医药大学 | 一种控制癌性疼痛的药物的制备方法及其应用 |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1403123A (zh) * | 2002-10-19 | 2003-03-19 | 吉林省辉南长龙生化药业股份有限公司 | 一种治疗跌打损伤的三七伤药及制备方法 |
-
2006
- 2006-04-19 CN CNB2006100108327A patent/CN100368002C/zh not_active Expired - Fee Related
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1403123A (zh) * | 2002-10-19 | 2003-03-19 | 吉林省辉南长龙生化药业股份有限公司 | 一种治疗跌打损伤的三七伤药及制备方法 |
Non-Patent Citations (2)
Title |
---|
外敷疗法临床应用. 韦麟.中医外治杂志,第14卷第1期. 2005 * |
癌性疼痛的中医药治疗近况. 林小武.华夏医学,第11卷第5期. 1998 * |
Also Published As
Publication number | Publication date |
---|---|
CN1876034A (zh) | 2006-12-13 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN100368002C (zh) | 一种外用止痛药物及其制备方法 | |
CN103405582B (zh) | 改善类风湿关节炎关节肿痛的中药组合物 | |
CN104740583B (zh) | 一种用于缓解克罗恩病的中药制剂及其制备方法 | |
CN1332702C (zh) | 一种治疗银屑病的药物 | |
CN102626478A (zh) | 治疗陈年腰肌劳损外用中草药组合物 | |
CN108686009A (zh) | 预防和/或治疗鼻炎的精油组合物、制备方法、应用和制剂 | |
CN102626477B (zh) | 治疗陈年跌打损伤外用中草药组合物 | |
CN101057922A (zh) | 一种治疗白癜风病的中药制剂 | |
CN103520289B (zh) | 一种治疗便秘的中药组合物及其制备方法和应用 | |
CN100400093C (zh) | 一种减轻患者疼痛的外用药 | |
CN103610777B (zh) | 一种治疗妊娠阑尾炎的内服中药 | |
CN100394976C (zh) | 一种中药戒毒药物 | |
CN104288385A (zh) | 一种戒毒中药 | |
CN1559573A (zh) | 妇炎康软胶囊及其制备方法 | |
CN101721610B (zh) | 一种治疗肿瘤的药物 | |
CN105663659A (zh) | 一种治疗便秘的中药组合物 | |
CN1077893A (zh) | 丹田健心膏制备方法 | |
CN102178732B (zh) | 一种治疗慢性湿疹的中药纳米乳喷雾剂 | |
CN101249250A (zh) | 一种治疗寒痰气滞血瘀阻络的胸痹·胸痛症的药酒制剂 | |
WO2002094297A1 (en) | Herbal composition for the treatment of drug addiction and insomnia | |
CN1225269C (zh) | 治疗三叉神经痛的药物 | |
CN106237156A (zh) | 一种治疗胃癌的中药组合物及其制备方法 | |
CN1169533C (zh) | 戒毒敷脐膏及其制作方法 | |
CN101229255A (zh) | 一种治疗急性腰部损伤的纯中药配方 | |
CN1123138A (zh) | 降压宁天然透皮保健浴液及其配制 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
C14 | Grant of patent or utility model | ||
GR01 | Patent grant | ||
ASS | Succession or assignment of patent right |
Owner name: YUNNAN CONBA PLANT EXTRACTS CO., LTD. Free format text: FORMER OWNER: XIONGYE PHARMACEUTICAL INDUSTRY CO., LTD., YUNNAN Effective date: 20121119 |
|
C41 | Transfer of patent application or patent right or utility model | ||
TR01 | Transfer of patent right |
Effective date of registration: 20121119 Address after: 655000 West Road, Qujing economic and Technological Development Zone, Yunnan Patentee after: Yunnan Conba Plant Extracts Co., Ltd. Address before: 655000 West Road, Qujing Economic Development Zone, Yunnan Patentee before: Xiongye Pharmaceutical Industry Co., Ltd., Yunnan |
|
C41 | Transfer of patent application or patent right or utility model | ||
TR01 | Transfer of patent right |
Effective date of registration: 20161110 Address after: 650217 Yunnan city of Kunming Province Economic and Technological Development Zone No. 1 and Taolu Patentee after: Yunan Xitao Green Pharmaceutical Co., Ltd. Address before: 655000 West Road, Qujing economic and Technological Development Zone, Yunnan Patentee before: Yunnan Conba Plant Extracts Co., Ltd. |
|
CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20080213 Termination date: 20170419 |
|
CF01 | Termination of patent right due to non-payment of annual fee |